Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pane

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Haematologica|May 9, 2000
Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemiaA Camera, L Pezzullo, M R Villa, et al.
Annals of Hematology|July 24, 2018
(1-3)-β-D-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observationsM Picardi, R Della Pepa, C Giordano, et al.
Blood|February 1, 1996
Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosisG Saglio, F Pane, E Gottardi, et al.
Haematologica|August 27, 1998
Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresisG Martinelli, N Testoni, V Montefusco, et al.
Leukemia|July 14, 2006
TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemiaR Rosati, R La Starza, L Luciano, et al.
Bone Marrow Transplantation|February 10, 2015
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?R Tamari, T I Mughal, D Rondelli, et al.
Blood Advances|May 16, 2019
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphomaM Picardi, R Della Pepa, C Giordano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patientsG Martinelli, I Iacobucci, G Rosti, et al.
Leukemia|September 26, 1997
JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesisR Di Noto, L Luciano, C Lo Pardo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 15, 2016
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registryRoberta Della Pepa, M Picardi, F Sorà, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Haematologica|May 9, 2000
Coexistence of two distinct cell populations (CD56(+)TcRgammadelta(+) and CD56(+)TcRgammadelta(-)) in a case of aggressive CD56(+) lymphoma/leukemiaA Camera, L Pezzullo, M R Villa, et al.
Annals of Hematology|July 24, 2018
(1-3)-β-D-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observationsM Picardi, R Della Pepa, C Giordano, et al.
Blood|February 1, 1996
Consistent amounts of acute leukemia-associated P190BCR/ABL transcripts are expressed by chronic myelogenous leukemia patients at diagnosisG Saglio, F Pane, E Gottardi, et al.
Haematologica|August 27, 1998
Detection of bcr-abl transcript in chronic myelogenous leukemia patients by reverse-transcription-polymerase chain reaction and capillary electrophoresisG Martinelli, N Testoni, V Montefusco, et al.
Leukemia|July 14, 2006
TPM3/PDGFRB fusion transcript and its reciprocal in chronic eosinophilic leukemiaR Rosati, R La Starza, L Luciano, et al.
Bone Marrow Transplantation|February 10, 2015
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?R Tamari, T I Mughal, D Rondelli, et al.
Blood Advances|May 16, 2019
Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphomaM Picardi, R Della Pepa, C Giordano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patientsG Martinelli, I Iacobucci, G Rosti, et al.
Leukemia|September 26, 1997
JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesisR Di Noto, L Luciano, C Lo Pardo, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 15, 2016
Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registryRoberta Della Pepa, M Picardi, F Sorà, et al.
Pageof 9